Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Alex Blostein
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 141on tracked calls
- Challenge rate
- 9%12 of 141 questions
- Companies
- 18questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 141 of 141 questions from 18 companies
RJFRaymond James Financial16 questions · 8 reporting periods · 2 of 16 challenging
Calendar 2026 Q2
just a cleanup on the legal reserve, how much was that this quarter?
Show response
Paul declined to disclose the specific figure but confirmed it drove most of the professional-fee increase; partially answered.
talk about the ability to drive positive operating loans from here if the banking backdrop does not really improve
Show response
Butch confirmed the firm is at its ~20% adjusted pretax margin target while investing in growth, citing rates and M&A as catalysts.
Calendar 2026 Q1
Where are the odds of that today? So you sort of think about your pipeline of corporate M&A, particularly in the wealth space
Show response
Shoukry noted great competitors with strong cultures simply haven't been for sale. RJF invites firms to join the family rather than doing takeovers. Cited Morgan Keegan (2012) where legacy leadership still in place and Memphis headcount has grown. Patient approach, maintaining relationships with friendly competitors. Confident families will join at some point.
what do you think the margins could go to over time
Show response
Shoukry acknowledged significant Agentic AI opportunities ahead but called it too early to dimension margin impact. Currently piloting Ray with hundreds of advisers with extremely positive early feedback. Using AI in cybersecurity and other areas. Compute power investment substantial. Corporate America broadly still early in Agentic AI journey.
Calendar 2025 Q4
Can you maybe elaborate on what specifically is going into that growth this year
Show response
Shoukry cited cybersecurity, AI application development, and infrastructure investment. Noted smaller firms struggle to remain competitive without $1B+ annual technology spend. Recruited advisers discovering technology gap after moving. Long-term AI efficiency gains expected but too early to dimension or put timeline on.
It seems the past couple of quarters has been closer to like $350 to $400 million range, including the target for the fiscal second. Can you kind of walk through the rationale
Show response
Shoukry framed Q1 as $400M buyback plus $80M preferred redemption = $480M total capital deployment. Reiterated $400-500M quarterly buyback target going forward while monitoring Tier 1 leverage ratio. Will adjust if other capital priorities arise.
Calendar 2025 Q3
Maybe can you expand on some of the financial parameters, the criteria that you guys would look for, for a larger-sized deal
Show response
Shoukry reiterated three criteria: cultural fit (most important), strategic fit (1+1 > 2 with leadership retention track record), and valuation. Cited Morgan Keegan (2012), consumer IB, and TriState as examples of retained leadership. Have lots of capital/liquidity and actively looking across all businesses.
was this related to GreensLedge acquisition in the quarter? Or should we take it as a signal that maybe there's something bigger that's imminent
Show response
Oorlog explained buyback pause was from senior note offering, not M&A signaling. Combined $350M buybacks + $98M sub-note redemption = $450M total capital deployment, within $400-500M quarterly target. Shoukry confirmed target unchanged going forward.
Calendar 2025 Q2
Is the pipeline in banking what are you seeing right now and stuff that's sort of tangible enough to get you guys into that 20-plus percent pretax margin goal
Show response
Oorlog noted 19% adjusted pretax margin was solid given capital markets softness. Improvement in capital markets plus 8% increase in fee billable assets for Q4 provide tailwinds to reach 20% target from Investor Day.
How are you thinking about that for AJ? It feels like the opportunity to increased penetration of alternative products
Show response
Shoukry emphasized headroom in private markets penetration. New leadership team in place for 4 months investing in education and awareness. Will not push products or create quotas/variable incentives. Demand-driven approach consistent with culture.
Calendar 2025 Q1
Maybe spend a minute on kind of what does that look like today at RayJay
Show response
Shoukry described wide product range from alternative mutual funds to private investments for $50M+ clients. Open architecture platform with new private placements head bridging Capital Markets and PCG. Penetration still relatively low.
what's been, I guess, the problem in the last year or so? What do you think could change to get you guys back to this 5% plus
Show response
Shoukry pushed back on characterization, noting last quarter was 4% (mid-5s ex-OSJ departure). Emphasized March and April new commits accelerating. Confident in best-in-class NNA growth trajectory.
Calendar 2024 Q4
how much the underlying drivers of the business have expanded over the last couple of years
Show response
Reilly cautioned against extrapolating last two quarters as run rate. Q4 and Q1 benefited from early recovery and large individual fees. Pipeline strong but M&A is inherently lumpy.
can you give us a sense of realistically when you expect to get there not to pin you down to any particular quarter
Show response
Shoukry asked for patience noting they were at 10% just two years ago and did six acquisitions in that period. Reilly noted they decelerated buybacks prudently due to active acquisition due diligence.
Calendar 2024 Q3
Should we assume that to be kind of run rate quarterly pace of buybacks from here as well or absent, obviously, like M&A
Show response
Shoukry reiterated preference for organic growth and acquisitions over buybacks. Will maintain or increase buyback pace to limit further capital ratio expansion above 10% target.
Is it possible to unpack sort of sources of growth you saw in the third quarter, your fiscal fourth quarter across the cash stack
Show response
Shoukry attributed cash growth to new advisor onboarding, previously masked by reinvestment activity. Decelerating reinvestment revealing underlying organic cash growth.
BNYBNY Mellon13 questions · 7 reporting periods · 0 of 13 challenging
Calendar 2026 Q2
how do you think deposit betas will perform both in the U.S. and outside the U.S.
Show response
Dermot guided deposit betas roughly in line with the last cycle, about 80% for dollars and 60-70% for euros and sterling, noting BNY is predominantly a dollar book.
what the destination for profitability could be, in the business as a whole over the next couple years
Show response
Dermot framed the medium term targets as through cycle miles rather than endpoints and declined to put a specific number on the profitability ceiling.
Calendar 2026 Q1
how does that inform your 10% NII guide
Show response
CFO expects balances to moderate seasonally from Q1 with Q3 weakest and Q4 strongest. Over the full year, balances expected modestly higher than 2025. Multiple rate and balance scenarios run to support the 10% NII guide.
how much of the benefit the elevated market volatility contributed this quarter to think about the right baseline
Show response
CFO described balanced revenue between volume-driven and balance-driven fees, with balanced equity/fixed income mix. Noted 3% investment-related gains contribution to Securities Services 39% PTM. Record sales quarter shows clients doing more across platforms.
Calendar 2025 Q4
as you think about organic fee growth into '26 and beyond, any way to frame what that could look like
Show response
CFO cited three consecutive years of core fee sales growth, 64% increase in multi-product clients, and 10% of sales from new logos. New Chief Product and Innovation Officer expected to drive similar impact as commercial model. CEO added multiple megatrends as tailwinds.
I don't think I heard you guys talk about the capital return plans for 2026 specifically
Show response
CFO said capital philosophy unchanged with Tier 1 leverage ratio target at upper end of 5.5-6% range. Total payout ratio expected in 95-105% range, consistent with prior years. No longer feels necessary to separately guide on buybacks given overall algorithm.
Calendar 2025 Q3
as you think about firm-wide margin in this kind of mid-30s year to date and as you think about the forward opportunity set
Show response
CFO cited consistent delivery above best-in-class 150bps operating leverage benchmark over three years. Still early in decade-long transformation with platform benefits, product innovation under new CPO, and AI opportunities not yet factored in.
if you think about Q4 guide, is that a reasonable jumping-off point for NII for all of 2026
Show response
CFO confirmed proactive 2026 balance sheet repositioning has been done, replicating the Jackson Hole pivot approach, and stated Q4 is a good base case jumping-off point for 2026 NII.
Calendar 2025 Q2
where do you see both risk to, you know, the existing business and some of the new revenue opportunities
Show response
CEO saw net positive from digital disruption, noting BNY provides traditional banking rails, on/off-ramp services, native Bitcoin custody, and stablecoin reserve custody spanning multiple platform synergies.
Calendar 2025 Q1
Can you comment also on the mix between interest-bearing and noninterest-bearing in April
Show response
CFO attributed NII confidence to proactive balance sheet actions taken after Jackson Hole last summer, noting even 50bp Fed cut would not materially impact the full-year NII outlook.
How are you thinking about that? Maybe it's too early, but just want to get your sense for appetite for M&A
Show response
CEO emphasized disciplined approach to M&A with clear criteria: strategic alignment, cultural fit, and attractive returns. Cited Archer acquisition as practice for future integration capabilities.
Calendar 2024 Q4
We've seen stronger results in the repo business for a handful of quarters now
Show response
CEO noted repo is roughly 5% of total NII, so while investments have improved performance, it remains a small contributor. Expect growth but not a meaningful driver of total NII.
how important is fee operating leverage to the firm? I know you talk about total, which is right
Show response
CFO confirmed focus on both total and fee operating leverage through the cycle, noting multiple levers across NII, fees, and expenses provide flexibility to deliver the target.
IVZInvesco12 questions · 7 reporting periods · 1 of 12 challenging
Calendar 2026 Q2
how reliant are your gross sales in the QQQs from areas that can have just more sensitivity
Show response
Schlossberg cited breadth of the shareholder base and the proxy solicitation experience as evidence of low fee sensitivity, but gave no channel-level split of gross sales.
how quickly do you expect that to phase out in 2027? So does that all kinda go away in the first quarter
Show response
Dukes described a taper starting in Q1 2027 with some bleed-through but deferred formal 2027 guidance until closer to the year.
Calendar 2026 Q1
what does that look like today? And is there enough there to move the needle on the blended fee rate when it comes to that bucket as well for you guys?
Show response
Andrew noted 14 new launches ($2.5B inflows) but 75% of flows from existing products. Allison acknowledged new products launch at slightly lower fee rates but margins in high 50s to low 60s demonstrate platform strength. Fee rate compression likely to continue as mix shift story.
anything you guys would be willing to share and how you would potentially respond if competitors come in at a lower price point?
Show response
Andrew emphasized level licensing fees, total cost of ownership including spreads and liquidity, 25-year brand history with hundreds of millions invested, and ETF investors' demonstrated insensitivity to marginal fee differences.
Calendar 2025 Q4
Maybe it would be helpful just to kind of level set where you guys expect the total dollar amount of expenses to be for 2026, assuming sort of flat markets
Show response
Allison declined to give total 2026 expense figure but confirmed $3.2B is right starting point, with 25% variable assumption and comp-to-rev around 40-41%. Committed to continuing operating margin expansion with mid-30s target on path to high-30s.
do you still see parts of the business that are sort of subscale where you could do something similar where you exit them or JV them or kind of try to maneuver them to where sort of it makes sense?
Show response
Andrew indicated foundational restructuring largely complete, shifting focus to execution across ETFs, SMAs, private markets, and Asia/EMEA growth. Allison noted no obviously subscale businesses remain but significant opportunity for performance improvement.
Calendar 2025 Q3
Maybe one, with the use of proceeds, obviously, you guys have been deleveraging, and there's more to do there, but maybe talk a little bit about capital return priorities as you look out over the n...
Show response
Allison detailed India ($140-150M proceeds, ~$6M/quarter OI impact) and Intelliflo ($100M proceeds, negligible OI impact). Capital priorities remain balanced: balance sheet improvement, 60% payout ratio, and growth investment. Total divestiture proceeds of $240-250 million.
Calendar 2025 Q2
curious how you're thinking about the licensing fee of 8 basis points relative to other rates that are out there in the market, how durable do you think that's going to be?
Show response
Andrew declined to comment beyond the proxy, characterizing NASDAQ and Bank of New York as outstanding partners with no indication of fee renegotiation.
Calendar 2025 Q1
how you envision sort of the product and distribution opportunities develop with Barings and MassMutual
Show response
Andrew indicated first phase focuses on private credit for US wealth management, happening relatively quickly, with second and third phases following.
what ultimately got MassMutual over the hump to agree to this
Show response
Allison cited multi-faceted partnership strength. Noted MassMutual is 18% common shareholder invested in stock rerating. Future discussions possible under repurchase agreement.
Calendar 2024 Q4
what are the runrate expenses you expect to pay State Street once all the assets have migrated over?
Show response
Allison declined to share State Street fee specifics citing contractual constraints but confirmed implementation costs of $10-15M/quarter will end post-migration.
talk to us maybe a bit about the pipeline that you are seeing in the products there and your expectations for flows over the next couple of quarters?
Show response
Andrew highlighted equity ETF demand growing in China, with balanced fixed income plus strategies also gaining traction amid government stimulus.
STTState Street Corporation11 questions · 6 reporting periods · 2 of 11 challenging
Calendar 2026 Q2
So as you think about the firm wide organic fee growth today, where does that stand
Show response
Woods framed positive operating leverage as the north star, with the $250M revenue uplift led by alternatives.
Calendar 2026 Q1
can you give us the overarching goals you are trying to achieve?
Show response
John outlined four building blocks for July update: 1) increasing business execution discipline driving organic growth, 2) distinctive portfolio of strategic initiatives (digital, wealth, privates), 3) operating model transformation with agile ways of working, and 4) technology modernization and AI. Current guide implies ~31% pretax margin. Goal is both growth and improved profitability over medium term.
Any early thoughts on the implications that might have on both ETF growth for State Street Corporation and incremental expenses
Show response
Ron noted these platforms are close partners. STT has broadened from institutional to wealth and international channels. Any pocket impacts won't be substantial given the diversified ETF franchise.
Calendar 2025 Q4
it just feels like there's no organic growth really baked in in your 2026 numbers
Show response
John clarified: flat markets put fee revenue above midpoint of 4-6%; 5% market growth reaches upper end. Organic growth in 2025: ~2% servicing fees, ~3-4% management fees. Software transitioning from on-prem to SaaS creates temporary reporting headwind but underlying organic growth is high single digits. Markets business provides additional growth, variable with volatility.
should we expect a larger buyback or a larger payout for 2026?
Show response
John noted 2025 payout was right around 80%, slightly below target due to late FDIC windfall increasing denominator, not lower dollar buyback. 2026 capital waterfall: protect/grow dividend, deploy RWA for client lending and markets, bolt-on M&A, then strong buyback. CET1 is the lead optimization metric despite technical leverage constraint.
Calendar 2025 Q3
is it a function of the balances being higher? I know that tend to pick up seasonally. Or is there something more more specific that you guys are already starting to work through?
Show response
John said balance sheet expected to be about stable in Q4, not the driver of NII improvement. Real drivers are investment portfolio reinvestment at higher yields and terminated interest rate hedges with negative drag running down in Q4, both continuing into 2026. Non-interest-bearing deposits held in and expected to continue stable.
How are you thinking about, both the balance sheet management and sort of operating dynamics in the company?
Show response
John outlined four priorities: partnering with management on execution/profitability, balance sheet optimization opportunities, productivity initiatives with tailwinds into 2026, and geographic expansion/product development. Noted solid deposit trends and NIM flat QoQ with NII/NIM headed up in Q4.
Calendar 2025 Q2
the redemptions have been fairly elevated. Obviously, part of that is BlackRock. But are you, I guess, aware of anything notable on the redemption side that could sort of offset some of the strong ...
Show response
Ron emphasized operating model investments driving improved service quality, which both raises retention and enables wins. Alpha driving wins across the stack. Mark provided historical context: $140-160M sales in 2019-2020, now $145M in Q2 alone, 'That's more in the second quarter than we did in all of 2020.'
help us maybe think about what are the things you guys could do and what are you working on to perhaps mitigate the effects of lower interest rates as you look out beyond this year
Show response
Mark declined to get into 2026 specifics but mentioned deposit pricing, balance sheet strategy, and investment portfolio positioning as active areas of focus.
Calendar 2025 Q1
I was hoping you can bifurcate between interest-bearing and non-interest deposits trends
Show response
Mark noted NIB decline came from asset manager and asset owner clients, expected from seasonal Q4 highs. Client deposits now tracking toward $240 billion high end of range.
what holding up better in the business to fill the gap, I guess, from the market impact on fees in 2025 to keep your guidance largely intact
Show response
Ron cited installation backlog and pipeline momentum. Mark highlighted $370M trailing four-quarter sales and record $356M to-be-installed revenue as core business momentum that hasn't changed.
BENFranklin Resources10 questions · 7 reporting periods · 0 of 10 challenging
Calendar 2026 Q2
How are you thinking about the opportunity in fixed income broadly and how much they could accelerate growth for Franklin
Show response
Johnson described a unified public-private fixed income platform of $620 billion including $100 billion private, plus Western integration; Gamba cited multi-asset credit wins. Direct.
maybe it’s worthwhile just kind of fleshing out how you think about buybacks from here and the capital management approach
Show response
Nicholls detailed capital priorities and explained that the elevated buyback included repurchasing Great-West Life's stake above its 4.9% lockup. Direct.
Calendar 2026 Q1
I was hoping you could break that down by key strategies as well as whether Lexington, their flagship fund, contributed to that at all
Show response
Jenny: credit was largest contributor, Lexington meaningful but can't detail flagship. Over 30 vehicles contributed across credit, secondary PE, real estate, venture. No catch-up fees. Lexington on track, flagship update via filing in second half of year. Expect to exceed $30B annual target. Matt clarified: approximately 90% of alt AUM has fee-earning potential, current fee-generating is about 80% of $283B total.
Calendar 2025 Q4
Where do you see the profitability over time? Many of your peers are well in the thirties
Show response
Matt stated 30% margin target in fiscal 2027, 30-35% achievable over 5-year plan. Western support costing several points of margin. High 20s margin guidance for FY2026 assumes flat markets. If markets stay current levels, upside to plan. Scaling of ETFs, Canvas, and Solutions creating higher margins at current size despite lower fees.
Calendar 2025 Q3
your just total expense guide for 2026 in totality?
Show response
Matt confirmed $200M gross efficiencies achieved, now determining net amount. Self-funding growth investments, absorbing Apera ($30M), increased fundraising expenses, and Aladdin project. Market up 15-20% to start year helps. Margin expected to tick up each quarter (Q1 lower by ~2% from accelerated deferred comp). Targeting 30% margin.
Can you just unpack how much you assume for Lexington's flagship fund?
Show response
Jenny detailed $25-30B FY2026 target as mix of Lexington (up to half), Clarion, BSP, Alcentra, and Venture. Prior year achieved $22.7B even without Lexington first close. Expects FY2026 to be well-rounded across all alt managers.
Calendar 2025 Q2
expense guidance just as you kind of progress here towards the end of the fiscal year
Show response
Matt gave detailed Q4 guidance: comp $860-870M (includes $100M perf fees at 60% payout), IS&T $155M, occupancy $69-70M, G&A $190-195M. Total ~$1.283-1.285B. FY2025 slightly above flat ($20-30M higher) despite higher markets. FY2026: $200M+ run rate savings minus Apera ($30M) and potential higher alt distribution expenses.
I wanted to get your guys' thoughts on the outlook for private markets growth for Franklin over the next 12 months
Show response
Jenny updated alt fundraising to ~$18.5B expected for FY2025. Lex Fund XI first close pushed to December 2025 or early 2026. Wealth channel at 25% of YTD fundraising. Flex and Flex International seeing $150-200M/month. Added 16 international distributors. BSP perpetual real estate debt fund launched with 1 wirehouse, expanding internationally. 90 dedicated alt specialists, still adding headcount.
Calendar 2025 Q1
would love to get your insight on how the retail products have done, through April
Show response
Private markets at $10.4B of $13-20B target. Lexington Fund 11 first close pushed from September to later in 2025 or early 2026. Still expect mid-range of fundraising target. Fund 11 expected bigger than Fund 10's $22.7B.
Calendar 2024 Q4
can you help us frame the operating income and management fee contribution from Western, kind of where that stands today?
Show response
Matt detailed Western at ~6% of Franklin adjusted revenue remaining. $120B outflows = 30% of Western's FY24 revenue = 3% of Franklin. Integration of corporate functions accelerated as 5-year autonomous agreement expires July.
ARESAres Management Corporation8 questions · 7 reporting periods · 0 of 8 challenging
Calendar 2026 Q2
where on your priority list is something inorganic on the private equity side?
Show response
Mike declined to address deal rumors but laid out the M&A framework (culturally, strategically, and financially accretive) and made the case for scaling private equity.
Calendar 2026 Q1
Can you expand on which parts of the Credit business you have seen the biggest incremental pickup in deployment opportunities
Show response
Arougheti pushed back on the premise that non-traded BDCs were the incremental buyer, noting the diversified deployment across Infrastructure, Real Estate, European Direct Lending, and Secondaries.
Calendar 2025 Q4
can you unpack that a little more between direct lending products versus other well vehicles that you guys have
Show response
Mike emphasized intentional slow wealth channel build to maintain institutional drawdown buffer. January $1.2B and February tracking similarly. ACI saw $750M inflows in Jan-Feb vs $200M prior year. About 95% of investors not seeking liquidity. Some outflows driven by small number of investors repeatedly queuing.
Calendar 2025 Q3
how you envision your franchise position in case LP appetite starts to normalize and resume in the real estate channel
Show response
Mike highlighted third largest institutional real estate manager position, vertical integration, and 51% QoQ / 78% YoY deployment growth in real estate. Identified supply constraint tailwinds and rate-driven transaction volume recovery.
Calendar 2025 Q2
how compression in U.S. direct lending spreads impacting institutional demands and fee rates
Show response
Mike pushed back on fee pressure narrative, noting some peers cutting fees to attract capital. Private credit spreads 100-200bps wide vs liquid loans, high-grade book 60-90bps wide. Growth driven by consolidated market share gains.
Calendar 2025 Q1
what are the more likely areas of deployment where the firm could stay active?
Show response
Mike cited historical resilience: FPAUM grew 23% in 2022 when M&A was down 25%. Identified opportunistic credit (ASOF), secondaries, alternative credit, and ARCC pivot capacity as key deployment areas when M&A slows.
Calendar 2024 Q4
Can you guys just level set and remind us what their 2024 full-year management fee base is
Show response
Jarrod detailed $200M FRE in first 12 months, $245M in 2026, with $10M synergies and $10M integration costs. Mike added near-term fundraising pipeline of approximately $8B across data centers and real estate.
can you talk a little bit about the changes you're seeing in that LP base?
Show response
Mike noted high-grade demand is predominantly insurance-focused with some bank partnerships and sovereign interest. Viewed as distinct from sub-investment-grade private credit expansion.
Show 12 more companies
NTRSNorthern Trust8 questions · 4 reporting periods · 0 of 8 challenging
Calendar 2026 Q1
With the Visa shares become available to you guys this year. Can you maybe just talk through the amount of proceeds you expect the use of these proceeds and timing when it comes to potentially bigg...
Show response
Fox said approximately $470M pretax ($350M posttax) from half the Visa position. Not planning to use the same playbook as a few years ago, weighing against other priorities. Haven't landed on specific use yet.
Can we talk through maybe the areas where you see the most opportunity to accelerate growth? And ultimately, what you think Northern's organic fee growth, so, ex markets, should look like over the ...
Show response
O'Grady detailed growth levers by segment: WM needs talent additions plus digital marketing and centers of influence; AS focused on scalable growth within current footprint at profitable margins; AM investing in ETFs, tax-advantaged equity, and quant with third-party distribution buildout. Targeting 3% organic growth firm-wide but hopes to exceed.
Calendar 2025 Q2
how you're thinking about the trajectory from NII off of that jumping off point? And are there any things you could do today to mitigate the effects of potentially lower interest rates
Show response
Fox highlighted $1.5B quarterly securities rolloff reinvested at 100bp above runoff yield, deposit pricing focus across multiple currencies, and extending duration to protect not just H2 2025 but 2026 as well.
as you think about how long it will take you guys to get there, and ultimately, what interest environment does that contemplate?
Show response
O'Grady estimated 2027 timeline under a normalized yield curve with gradual rate declines, noting current quarters provide chunkier operating leverage gains while acknowledging some periods will require more grinding.
Calendar 2025 Q1
give us an update on kinda how things stand so far in April both in terms of the level and the mix
Show response
Fox confirmed deposit levels holding well into April with clients maintaining risk-off positions. No expectation of near-term abatement.
the percentage of your expense base that flexes directly with lower asset levels?
Show response
Fox noted very low variable expense ratio of less than 0.5%, meaning expense reduction from lower markets is minimal. 10% market decline translates to roughly 3% trust fee change.
Calendar 2024 Q4
has that changed at all, meaning that if you are in a sort of better fee environment in 2025
Show response
O'Grady acknowledged some variable cost but emphasized driving the expense curve down regardless of revenue environment.
as you think about the expense to fee ratio, which would kind of normalize for that flex, so to speak
Show response
O'Grady declined to give a specific 2025 target but confirmed continued progress toward the 105-110% medium-term range from current 113%.
APOApollo Global Management7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
what pools of investing capital do you think this will open up for Apollo and perhaps some of the others
Show response
Rowan mapped daily NAV and transparency to new capital pools: 401(k)/DC, traditional asset managers, and individual investors.
Calendar 2026 Q1
the durability of the origination volumes and the transaction fees you guys are seeing
Show response
Zelter emphasized growth across Apollo's proprietary ecosystem beyond platforms, highlighting AI infrastructure financing and partnership with banks. Rowan added this extends to energy, defense, and manufacturing globally.
Calendar 2025 Q4
it's been a little bit more turbulent with redemptions picking up and sales have generally slowed down, and that's really even before all the software headlines
Show response
Zelter noted ADS had net new assets up every quarter in 2025 with over $5B net inflows. Software exposure negligible on PIK, ARR, and pre-2022 vintage bases. Expect to gain market share and highlighted ABC as diversification opportunity.
Calendar 2025 Q3
I was intrigued by your comments around the asset management partnerships broadly. So maybe you could expand a little bit on how you view this $5 billion trajectory from here?
Show response
Rowan outlined a tiered wealth strategy: family offices (direct), HNW (via intermediaries), and mass market (via traditional manager partnerships). Expects billions at a time from traditional asset manager partnerships.
Calendar 2025 Q2
double-click into credit spread dynamics and importantly, how that could impact the insurance business perhaps beyond 2025
Show response
Rowan explained COVID-era spread runoff as the reason for current SRE compression, with a meaningful tick up expected once it completes. Pivoting origination away from commoditized CLOs to proprietary products.
Calendar 2025 Q1
When you think about how your institutional client base is responding and appreciate you guys actually don't have a large flagship fund in the market today
Show response
Zelter and Rowan both emphasized Apollo has historically under-earned its share of institutional assets, sees increasing insurance client demand, and views origination as the binding constraint.
Calendar 2024 Q4
your expectations for origination into 2025. The way you framed it, I thought it was really helpful between Atlas lender finance, and direct lending.
Show response
Zelter provided a comprehensive breakdown of geographic expansion plans for Atlas, growth in high-grade capital solutions and hybrid origination, and the bank partnership pipeline.
BLKBlackRock7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
Larry, I was hoping to go back to your comments around GIP and HPS performing ahead of the plan
Show response
Larry quantified 2026 insurance mandates, described the $800 billion insurance asset base conversion opportunity, and stressed HPS/GIP origination integration.
Calendar 2026 Q1
You mentioned in your prepared remarks that in prior periods of dislocation, BlackRock, Inc. tends to gain share
Show response
Larry highlighted positioning in retirement, infrastructure, iShares breadth. Martin noted top five managers capture 80%+ of flows, with structural growers and whole-portfolio consolidation as dual growth vectors.
Calendar 2025 Q4
how should we think about that progressing over the course of '26, assuming kind of normal markets?
Show response
Martin detailed FRE margin trajectory toward 50%+ driven by private markets growth. Ex performance fees, Q4 margin was 45.5%, up 30bps YoY. Mid-single-digit G&A increase expected for 2026 after annualizing HPS/Preqin. Headcount broadly flat.
Calendar 2025 Q3
what the HPS team is seeing on the ground, both with respect to credit trends across their direct lending portfolios in the third quarter
Show response
Martin explained headlines about private credit stress are in syndicated bank loan and CLO markets, not large direct lending books. Private credit lenders have more control over agreements and information. HLEND and B debt seeing steady allocations with strong deployment.
Calendar 2025 Q2
help us sort of think through the cadence and scaling of the business as these 2 acquisitions kind of come into the full run rate
Show response
Martin explained Q2 margin of 43.3% down 80bps driven by lower performance fees. Entry rate into Q3 approximately 10% higher including HPS. Controllable expenses aligned with 7% organic revenue growth. Expects acquisitions to be self-funding with double-digit FRE growth.
Calendar 2025 Q1
Does that mean BlackRock might need to get even larger outside the U.S.?
Show response
Larry said no acquisitions needed outside U.S.; partnerships with governments (India, Saudi Arabia, LatAm) and 40% European ETF market share provide sufficient scale. Expanding to 34-35 countries by year end.
Calendar 2024 Q4
to what extent does that change the backdrop you're seeing in the marketplace today?
Show response
Martin provided comprehensive breakdown of organic growth drivers across ETFs, private markets, fixed income, and cash. Larry added color on yield curve steepening and $10T cash rotation opportunity.
BXBlackstone Inc.7 questions · 7 reporting periods · 2 of 7 challenging
Calendar 2026 Q2
I would love to double click on what you guys are seeing in the wealth channel.
Show response
Gray reported wealth strength with muted BCRED flows recovering, and framed Wellington/Vanguard as additional distribution engines that take time to build.
Calendar 2026 Q1
the wealth channel is clearly still going through some growing pains, right? I mean, we see quite significant reaction in the channel
Show response
Gray pushed back firmly, arguing social media narrative diverges from facts. Cited BREIT's 9.5-year track record with only 1 year of limited liquidity and 60% return premium. Defended disclosure practices.
Calendar 2025 Q4
On the one hand, obviously, we saw redemptions pick up, not surprisingly, last quarter. Gross sales on gen one. Looks like they slowed down a little bit in BCRED still. So what is the sentiment fro...
Show response
Gray acknowledged BCRED redemption uptick from headlines but noted $14B gross sales in 2025 and $800M+ monthly inflows continuing. Institutional side accelerating with IG private credit delivering 180bps premium driving insurance demand.
Calendar 2025 Q3
how important is the sort of 10-ish percent gross return to the retail channel? So does the point you make, does that resonate or it's really viewed as an absolute product?
Show response
Gray said relative premium over liquid credit matters more than absolute return, BCRED flows remain healthy post-dividend cut, and multi-asset offerings will leverage BX's unique product breadth.
Calendar 2025 Q2
we're clearly seeing compression in credit spreads. And I'm curious how that's playing into your client conversations where the premium to liquid market is still there
Show response
Gray argued the enduring private-to-liquid spread premium is what matters, not absolute returns, and that demand remains extraordinarily robust across IG and non-IG globally.
Calendar 2025 Q1
curious to kind of how you think about the origination opportunity for Blackstone in IG private credit in light of potentially lose lending requirements on the bank side?
Show response
Gray argued BX's value proposition is bespoke flexibility and certainty of execution for borrowers, while banks can be origination partners rather than competitors.
Calendar 2024 Q4
Can you give us a sense of the amount of capital that's sitting on the platform now that's not earning fees yet that will turn on upon deployment?
Show response
Chae quantified ~$40B eligible but not yet earning fees in credit plus ~$9B in real estate credit, with Gray noting deployment should keep pace with inflows.
KKRKKR7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
talk through some of the biggest drivers of management fee growth into next year given the tough comps
Show response
Answered with the forward indicators (30-plus products, record committed capital not yet fee-bearing) but gave no fee growth rate for 2027.
Calendar 2026 Q1
As you think on the forward, it might be helpful just to get a mark-to-market on your expectations for fundraising
Show response
Craig detailed diversified fundraising across PE, credit, real assets and wealth. Flagships were only 15% of Q1 capital raised. Scott added consolidation theme is playing out with clients wanting to do more with fewer partners.
Calendar 2025 Q4
Can you talk maybe through the building blocks, your confidence levels in those building blocks?
Show response
Rob walked through FRE components: record capital raising driving management fee momentum, capital markets well-positioned for increased deployment, insurance capital markets fees scaling from ~$60M to hundreds of millions, fee-related performance revenue inflecting. Highlighted 46% mgmt fee growth vs 21% OpEx growth since end of 2022, inverse of three closest peers.
Calendar 2025 Q3
it might be helpful just to kind of go through the broader building blocks as you look through current fundraising dynamics
Show response
Rob confirmed leaning into the plus on $4.50 FRE target. $300B+ fundraising 70%+ achieved in 7 of 12 quarters. Capital Markets biased to upside in 2026. Fee-related performance revenue scaling materially.
Calendar 2025 Q2
Is that still the case? How are you sort of gauging the pulse of institutional clients as you go through this fundraising cycle?
Show response
Scott confirmed $217B raised in last 2 years, ahead of $300B+ target pace. Institutions consolidating relationships and doing more with fewer partners, benefiting KKR across infrastructure, credit, and ABF.
Calendar 2025 Q1
with the stock doing what it's done over the last few months, why not step up the buyback here?
Show response
Rob emphasized consistency in capital allocation framework across four buckets (buybacks, core PE, strategic M&A, insurance). Noted 30% management ownership alignment but gave no specific buyback commitment.
Calendar 2024 Q4
Could you just maybe walk us through sort of why now? Why is now the right time to add?
Show response
Craig explained SH owns ~20% of core PE businesses. Scott added Chubb investing alongside for the $2.1B+ add-on, with timing driven by partner liquidity needs and portfolio maturity.
NDAQNasdaq, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
how do you think about the margins as a whole over the next couple of years?
Show response
Sarah cited the widening revenue-to-expense gap and continued GenAI-driven efficiencies but gave no specific margin target.
Calendar 2026 Q1
I was hoping you can give us a little more detail on where you're seeing the incremental uptake, particularly within cap markets as well as your view for the rest of the year
Show response
Friedman attributed broad-based strength to trade management services connectivity demand and pricing increase, Calypso collateral management demand especially internationally, Market Technology Eclipse platform adoption and new intelligence suite data management add-on.
Calendar 2025 Q4
how are you thinking about M&A broadly? Is organic growth still the primary focus for the firm for the next call at couple of years?
Show response
Friedman reaffirmed organic growth as primary focus with bolt-on acquisitions evaluated in build versus buy orientation. Organic opportunity set described as tremendous with team fully focused on execution.
Calendar 2025 Q3
curious how you sort of think about areas of risk when it comes to AI with respect to Nasdaq's revenue model and as an offset potentially incremental revenue opportunities as well as areas where th...
Show response
Friedman described dual AI program: business-side automation of product development 'keep the lights on' work and client implementation/experience, product-side differentiation through proprietary data, deep domain expertise, and Agentic AI reducing compliance workflow time by 80%.
Calendar 2025 Q2
how we should be thinking about the momentum in fintech entering into '26
Show response
Friedman confirmed healthy pipeline maturity across all FinTech products globally, with Tier 1/2 FCMT revenue expected to ramp in Q4 and into 2026.
Calendar 2025 Q1
What is the probability of deals you're seeing out there Obviously, macro uncertainty could present pretty compelling valuation opportunities
Show response
Friedman clearly shut down M&A discussion, emphasizing laser focus on organic growth, deleveraging commitments, and Adenza returns before considering inorganic moves.
Calendar 2024 Q4
your outlook on Workflow and Insights. Obviously, it is a business that has been growing a little bit slower
Show response
Friedman acknowledged headwinds from slower IPOs and delistings, cited eVestment growing high single digits, and expects recovery as economic growth broadens.
ICEIntercontinental Exchange6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
how are you thinking about the mix and the revenue model evolving over time as you guys integrate this business?
Show response
Edmonds pointed to prior playbooks without naming a target mix. Gardiner added the concrete point that ICE is undersized in EMEA and Asia Pacific and can sell data into those regions.
Calendar 2026 Q1
the recurring revenue improvement sequentially, where that sort of coming from
Show response
Management detailed legacy renewal headwinds subsiding, 30% Encompass transaction growth, strong sales pipeline with JPMorgan, M&T, and Huntington Bank cross-sells.
Calendar 2025 Q3
What in terms of actual savings you guys think this can produce for the firm? What's the time frame on that?
Show response
Ben described AI enabling 'more with the same' headcount rather than direct cost savings. Speed to market for new products. Did not quantify specific dollar savings or margin impact timeline.
Calendar 2025 Q2
help us understand a little better how they could translate into either new or improved revenue opportunities for ICE as a whole
Show response
Chris said about half of current capacity built out with runway through early 2030s. Proprietary network under ICE control with scheduled buildout alongside client needs and power availability.
Calendar 2025 Q1
Can you kind of help us sort of think how that could impact the customers need to hedge and just sort of the broader activity in your energy markets
Show response
Ben emphasized growing risk factors (tariffs, recession, energy security, AI demand) driving more hedging. Open interest up 8% even on back of 30% energy growth proves market health.
Calendar 2024 Q4
ICE made a nice progress gaining market share over the course of last year. It looks like trends have picked back up again on the market share trend versus your primary competitor there
Show response
Ben Jackson attributed WTI gains to Midland WTI HOU contract innovation, physically delivered with double the deliveries of competitor. Cross-product trading efficiency drives bundled volume.
SCHWCharles Schwab Corporation6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
specifically zoning in on Q4 NIM guidance, which I think you said 3.25% to 3.30%
Show response
Attributed the flat Q4 NIM guide to the December rate-hike timing not benefiting 2026; expects further expansion into 2027.
Calendar 2026 Q1
what you're hearing on the ground from advisers with respect to their reception to Evergreen private alts
Show response
Wurster acknowledged alternatives allocation is relatively small today but expects 5-10 year growth, with opportunities to curate and monetize. Verdeschi noted long-short strategies are not capital-intensive due to netting but confirmed they monitor strategy evolution.
Calendar 2025 Q4
maybe just level set us what you assume for buybacks then? And again, how are you thinking about longer-term trajectory?
Show response
Mike confirmed 2026 scenario EPS does not include buybacks. Capital framework unchanged: 20-30% GAAP earnings dividend payout, potential preferred redemptions or replacements, and opportunistic buybacks above franchise growth needs.
Calendar 2025 Q3
how are you thinking of that over the next couple of quarters here? Because obviously, it's a pretty important component
Show response
Mike confirmed normalized cash environment with organic growth, seasonality, and sentiment as drivers. Lower rates expected to support further cash pickup heading into 2026.
Calendar 2025 Q2
How are you thinking about that? What do you think is the ultimate profitability destination for the firm
Show response
Mike pointed to balanced approach of investing in growth and scale/efficiency enabling natural margin expansion, though environment-dependent. Declined to give specific long-term target.
Calendar 2024 Q4
Could you guys spend a minute on your securities portfolio strategy as you roll through 2025
Show response
Mike confirmed ~$10B quarterly portfolio runoff will continue to fund supplemental paydown near-term, with reinvestment at higher yields an eventual opportunity.
AMPAmeriprise Financial5 questions · 3 reporting periods · 0 of 5 challenging
Calendar 2025 Q3
help us think about the reinvestment yields you expect on that book as that rolls off over the next couple of quarters
Show response
Walter confirmed reinvesting at high 4s to low 5s on maturities, maintaining bank NII. Comfortable with strategy for next 3 quarters, less certainty beyond depending on Fed and long-term rates.
those balances have been coming down now for several quarters, which makes sense, I guess, given how elevated they've been running at
Show response
Walter indicated certs balance decline is spread-driven and follows a predictable pattern. Pre-2023 levels of $5-6B may be the floor but doesn't expect precipitous drop at this stage.
Calendar 2025 Q2
I was hoping you guys can give us a sense of roll-on, roll- off dynamics in the bank securities portfolio
Show response
Walter confirmed portfolio maturities rolling into wider spreads, contributing to NII improvement. Funding loans through new liability products like CDs and high-yield savings.
Calendar 2025 Q1
how do you guys think that is likely to evolve here through 2025, relative to last year?
Show response
Walter confirmed CDs are incremental to existing sweep business. Bank earnings expected to be quite stable. Confident in ability to navigate Fed rate changes.
that gives you an opportunity perhaps to be a little more proactive, a little more opportunistic in this environment
Show response
Jim clarified it was a general statement about flexibility, not specific M&A targets. Board approved larger buyback program for market flexibility.
CMECME Group5 questions · 4 reporting periods · 1 of 5 challenging
Calendar 2026 Q2
You think the time is sort of ripe now for these to be more successful. Why now? I guess, what makes it different?
Show response
Terry framed the timing on market evolution; Tim gave equity-complex momentum stats and Julie Winkler covered retail distribution readiness.
Calendar 2026 Q1
Obviously, with a lot of volumes coming through, RPCs came down a bit
Show response
Lynne cited four factors: volume tiering at record levels, mix shift toward lower-priced crude, micro energy contracts surging from 80K to 315K ADV at $0.52 RPC, and more member trading.
curious to get your thoughts on the health of the underlying customer. Obviously, we've seen extreme volatility
Show response
Derek noted open interest in energy up 14% since Dec 31 with every client segment growing double digits led by commercials. Terry distinguished good vs bad volatility, noting headline volatility is normally short-lasting.
Calendar 2025 Q2
just curious how you could see your ecosystem impacted by this, whether it's in the rates business or any other products could potentially benefit
Show response
Terry views SLR relief as a net positive for CME. Mike Dennis noted it's still in public comment period with impact depending on bank-specific implementation.
Calendar 2025 Q1
You help break down the composition of retail in terms of just the revenues where that stands now?
Show response
Terry declined to share granular retail revenue breakdown but attributed durability to technology democratization, new brokers offering futures, and larger/more diverse retail market than prior cycles.
TROWT. Rowe Price5 questions · 5 reporting periods · 1 of 5 challenging
Calendar 2026 Q2
are there more significant action you could take to bring down the pace of expense growth more structurally
Show response
Dardis pointed to AI/tech productivity, third-party leverage, process automation, vehicle rationalization, and real-estate reductions, targeting low single-digit controllable expense growth. Direct.
Calendar 2025 Q4
how you guys are planning from an operating perspective for 2026. Heard this expense guide, so maybe just remind us of the ability to flex up or down
Show response
Rob emphasized market returns as primary margin driver; declined to comment on margin profile over time. Jen detailed expense guide components including controllable and market-driven buckets.
Calendar 2025 Q2
I was hoping to get your latest views on acquisitions for T. Rowe with respect to both thinking about opportunities in the 401(k) channel
Show response
Rob reiterated high M&A bar: cultural alignment, new capability, or client access. Jen added range of options now spans full acquisition to minority investment.
Calendar 2025 Q1
help us understand the drivers between sort of the original guide versus we are now. And as of what point, I guess, in April did you guys set the guide
Show response
Jen explained the move from 4-6% to 1-3% reflects both natural market-driven adjustment and intentional controllable expense management.
Calendar 2024 Q4
Is there room to bend that kind of non, sort of variable part of the expense base to be more aligned, with the organic revenue growth
Show response
Rob acknowledged need for structural cost reduction but emphasized continued investment in growth areas. Jen outlined 2-3% annual structural savings target.
CBOECboe Global Markets1 question · 1 reporting period · 1 of 1 challenging
Calendar 2026 Q2
How do you think that will impact competition in the space? What gives Cboe ultimately the right to win?
Show response
Craig defended the open all-to-all, centrally-cleared model's network effects over vertically integrated silos; Rob cited cross-market risk offsets; Prashant cited 50M+ retail clients on partner platforms. Direct.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| RJF Raymond James Financial | 16 | 13%2 of 16 questions |
| BNY BNY Mellon | 13 | 0%none of 13 questions |
| IVZ Invesco | 12 | 8%1 of 12 questions |
| STT State Street Corporation | 11 | 18%2 of 11 questions |
| BEN Franklin Resources | 10 | 0%none of 10 questions |
| ARES Ares Management Corporation | 8 | 0%none of 8 questions |
| NTRS Northern Trust | 8 | 0%none of 8 questions |
| APO Apollo Global Management | 7 | 14%1 of 7 questions |
| BLK BlackRock | 7 | 0%none of 7 questions |
| BX Blackstone Inc. | 7 | 29%2 of 7 questions |
- RJFRaymond James Financial · 16 questions13%2 of 16 questions
- BNYBNY Mellon · 13 questions0%none of 13 questions
- IVZInvesco · 12 questions8%1 of 12 questions
- STTState Street Corporation · 11 questions18%2 of 11 questions
- BENFranklin Resources · 10 questions0%none of 10 questions
- ARESAres Management Corporation · 8 questions0%none of 8 questions
- NTRSNorthern Trust · 8 questions0%none of 8 questions
- APOApollo Global Management · 7 questions14%1 of 7 questions
- BLKBlackRock · 7 questions0%none of 7 questions
- BXBlackstone Inc. · 7 questions29%2 of 7 questions
Show all 18 companies
| Company | Questions | Challenge rate |
|---|---|---|
| KKR KKR | 7 | 14%1 of 7 questions |
| NDAQ Nasdaq, Inc. | 7 | 0%none of 7 questions |
| ICE Intercontinental Exchange | 6 | 0%none of 6 questions |
| SCHW Charles Schwab Corporation | 6 | 0%none of 6 questions |
| AMP Ameriprise Financial | 5 | 0%none of 5 questions |
| CME CME Group | 5 | 20%1 of 5 questions |
| TROW T. Rowe Price | 5 | 20%1 of 5 questions |
| CBOE Cboe Global Markets | 1 | —Rate withheld: fewer than 3 questions |
- KKRKKR · 7 questions14%1 of 7 questions
- NDAQNasdaq, Inc. · 7 questions0%none of 7 questions
- ICEIntercontinental Exchange · 6 questions0%none of 6 questions
- SCHWCharles Schwab Corporation · 6 questions0%none of 6 questions
- AMPAmeriprise Financial · 5 questions0%none of 5 questions
- CMECME Group · 5 questions20%1 of 5 questions
- TROWT. Rowe Price · 5 questions20%1 of 5 questions
- CBOECboe Global Markets · 1 question—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 2 | 0%none of 2 questions | 1 |
| 2024 Q4 | 19 | 0%none of 19 questions | 14 |
| 2025 Q1 | 22 | 9%2 of 22 questions | 16 |
| 2025 Q2 | 21 | 10%2 of 21 questions | 17 |
| 2025 Q3 | 19 | 0%none of 19 questions | 14 |
| 2025 Q4 | 17 | 18%3 of 17 questions | 13 |
| 2026 Q1 | 21 | 10%2 of 21 questions | 15 |
| 2026 Q2 | 20 | 15%3 of 20 questions | 16 |
- 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2024 Q419 questions · challenge rate 0% (none of 19 questions) · 14 companies
- 2025 Q122 questions · challenge rate 9% (2 of 22 questions) · 16 companies
- 2025 Q221 questions · challenge rate 10% (2 of 21 questions) · 17 companies
- 2025 Q319 questions · challenge rate 0% (none of 19 questions) · 14 companies
- 2025 Q417 questions · challenge rate 18% (3 of 17 questions) · 13 companies
- 2026 Q121 questions · challenge rate 10% (2 of 21 questions) · 15 companies
- 2026 Q220 questions · challenge rate 15% (3 of 20 questions) · 16 companies
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth37
- Margin34
- Demand30
- Capital Allocation28
- Competitive Dynamics26
- M&A17
- Credit17
- Cost Pressure16
- Product Launch11
- Subscriber Growth11
Show all 18 topics
- Guidance Reliability9
- Pricing8
- Macroeconomic6
- Innovation & R&D5
- Cloud & AI5
- Regulation Policy4
- Geographic Expansion4
- Capex Investment3